Myomo Inc. (MYO)
undefined
undefined%
At close: undefined
6.26
0.32%
After-hours Dec 13, 2024, 08:00 PM EST

Company Description

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States.

The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.

Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders.

The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors.

Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Myomo Inc.
Myomo Inc. logo
Country United States
IPO Date Jun 12, 2017
Industry Medical - Devices
Sector Healthcare
Employees 101
CEO Paul R. Gudonis

Contact Details

Address:
137 Portland Street
Boston, Massachusetts
United States
Website https://www.myomo.com

Stock Details

Ticker Symbol MYO
Exchange AMEX
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001369290
CUSIP Number 62857J201
ISIN Number US62857J2015
Employer ID 00-0000000
SIC Code 3842

Key Executives

Name Position
Paul R. Gudonis Chairman, President & Chief Executive Officer
David A. Henry Chief Financial Officer
Colin Anderson Global Director of Operations
Dr. Harry Kovelman M.D. Chief Medical Officer
Galina Shtivelman Senior Director of Human Resources
Joseph Chicoskie Director of Marketing
Micah J. Mitchell Chief Commercial Officer

Latest SEC Filings

Date Type Title
Dec 05, 2024 8-K Current Report
Dec 05, 2024 424B5 Filing
Dec 04, 2024 424B5 Filing
Nov 06, 2024 10-Q Quarterly Report
Nov 06, 2024 8-K Current Report
Nov 05, 2024 4 Filing
Oct 18, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 04, 2024 4 Filing
Sep 09, 2024 4 Filing
Sep 05, 2024 4 Filing